Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000891293-10-000040
Filing Date
2010-10-01
Accepted
2010-10-01 19:10:40
Documents
1
Period of Report
2010-09-29

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 5864
  Complete submission text file 0000891293-10-000040.txt   7604
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Issuer) CIK: 0000891293 (see all company filings)

EIN.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
BIANCO JAMES A (Reporting) CIK: 0001198554 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12465 | Film No.: 101103764